Market closedNon-fractional
Applied Therapeutics/APLT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Applied Therapeutics
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
Ticker
APLT
Sector
Healthcare
Trading on
NASDAQ
Industry
Biotechnology
Headquarters
New York, United States
Employees
26
Website
www.appliedtherapeutics.com
APLT Metrics
BasicAdvanced
$594M
Market cap
-
P/E ratio
-$1.91
EPS
1.88
Beta
-
Dividend rate
Price and volume
Market cap
$594M
Beta
1.88
Financial strength
Current ratio
1.799
Quick ratio
1.756
Long term debt to equity
0.052
Total debt to equity
0.51
Management effectiveness
Return on assets (TTM)
-51.57%
Return on equity (TTM)
-612.33%
Valuation
Price to revenue (TTM)
-1,106.383
Price to book
8.85
Price to tangible book (TTM)
8.85
Price to free cash flow (TTM)
-7.865
Growth
Revenue change (TTM)
-104.47%
Earnings per share change (TTM)
24.35%
3-year earnings per share growth (CAGR)
-25.65%
What the Analysts think about APLT
Analyst Ratings
Majority rating from 5 analysts.
APLT Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$100K
-98.99%
Net income
-$84M
-29.91%
Profit margin
-83,900.00%
6,839.10%
APLT Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.37
-$0.47
-$0.34
-$0.67
-
Expected
-$0.27
-$0.26
-$0.23
-$0.16
-$0.18
Surprise
39.62%
81.23%
49.12%
320.06%
-
APLT News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Applied Therapeutics stock?
Applied Therapeutics (APLT) has a market cap of $594M as of July 27, 2024.
What is the P/E ratio for Applied Therapeutics stock?
The price to earnings (P/E) ratio for Applied Therapeutics (APLT) stock is 0 as of July 27, 2024.
Does Applied Therapeutics stock pay dividends?
No, Applied Therapeutics (APLT) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Applied Therapeutics dividend payment date?
Applied Therapeutics (APLT) stock does not pay dividends to its shareholders.
What is the beta indicator for Applied Therapeutics?
Applied Therapeutics (APLT) has a beta rating of 1.88. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Applied Therapeutics stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.